Franklin
Lakes, NJ -- Friday, October 27, 2000 -- BD (Becton,
Dickinson and Company) (NYSE: BDX), today applauded the U.S.
Senates unanimous consent passage of the Needlestick Safety and
Prevention Act (S.B. 3067). The U.S. House of Representatives passed
a similar bill (H.R. 5178) on October 4, 2000. The passage of both
bills reflects the strong bipartisan consensus in support of
legislation to guarantee healthcare workers access to
safety-engineered devices that will help protect them from
accidental needlesticks.
The passage of this legislation is a testament to the support
and dedication of our nations nurses, clinicians and other
healthcare workers who have worked diligently toward this victory
for years, said BD President and CEO Edward J. Ludwig. BD is
delighted to join government, healthcare providers, industry, labor,
regulators and thought leaders in the celebration of this
long-awaited healthcare worker safety milestone, and we urge
President Clinton to join Congress in making history.
The Senate legislation was introduced by Senator James Jeffords
(R-VT) and sponsored by Senators Edward Kennedy (D-MA), Mike Enzi
(R-WY) and Harry Reid (D-NV). Representative Cass Ballenger (R-NC)
introduced the House of Representatives legislation.
The Senate and House bills update the Occupational Safety and
Health Administrations (OSHA) Bloodborne Pathogens Standard to
require that employers make available for use sharps with
engineered sharps injury protection features and needleless
systems to reduce the risk to healthcare workers of occupational
exposure to HIV, hepatitis C and other diseases. In addition, both
bills require that healthcare workers responsible for direct patient
care participate in the evaluation of these products and mandate
that healthcare facilities update and review their Exposure Control
Plans to reflect changes in technology, such as safety-engineered
devices, and maintain a log of accidental needlestick occurrences.
Said Ludwig, It is important to note that the legislation will
protect healthcare workers without restricting the introduction of
newly developed technologies from any manufacturer, and will
safeguard industrys ability to supply customers with quality,
safety-engineered devices that deliver superior patient care.
BD pioneered the development of safety-engineered products over
12 years ago and is today the leading supplier of safety-engineered
medical devices. In July 2000, the Company launched the second wave
of the BD Safety Compliance Initiative, a comprehensive education
and training program to assist customers in complying with the new
OSHA Compliance Directive.
BD is 100 percent behind this legislation, added Ludwig. It
not only realizes a long-held dream of our Company, it also fulfills
the hopes of hundreds of thousands of healthcare workers whose well
being is essential to the well being of us all.
BD is a medical technology company that manufactures and sells a
broad range of supplies, devices, and systems for use by healthcare
professionals, medical research institutions, industry and the
general public. For the fiscal year ended September 30, 1999, BD
reported total revenues of $3.4 billion.
For more information on health care worker safety, visit
http://www.bd.com/safety.